Ascendis Pharma A/S

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ASND and other ETFs, options, and stocks.

About ASND

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. 

CEO
Jan Møller Mikkelsen
CEOJan Møller Mikkelsen
Employees
—
Employees—
Headquarters
Hellerup, Capital Region
HeadquartersHellerup, Capital Region
Founded
2006
Founded2006
Employees
—
Employees—

ASND Key Statistics

Market cap
18.06B
Market cap18.06B
Price-Earnings ratio
16.86
Price-Earnings ratio16.86
Dividend yield
—
Dividend yield—
Average volume
791.23K
Average volume791.23K
High today
$278.56
High today$278.56
Low today
$265.66
Low today$265.66
Open price
$267.72
Open price$267.72
Volume
816.91K
Volume816.91K
52 Week high
$282.15
52 Week high$282.15
52 Week low
$188.08
52 Week low$188.08

Stock Snapshot

As of today, Ascendis Pharma A/S(ASND) shares are valued at $275.39. The company's market cap stands at 18.06B, with a P/E ratio of 16.86.

On 2026-11-15, Ascendis Pharma A/S(ASND) stock traded between a low of $265.66 and a high of $278.56. Shares are currently priced at $275.39, which is +3.7% above the low and -1.1% below the high.

Ascendis Pharma A/S(ASND) shares are trading with a volume of 816.91K, against a daily average of 791.23K.

During the past year, Ascendis Pharma A/S(ASND) stock moved between $188.08 at its lowest and $282.15 at its peak.

During the past year, Ascendis Pharma A/S(ASND) stock moved between $188.08 at its lowest and $282.15 at its peak.

ASND News

Simply Wall St 12h
Ascendis Pharma Stock Looks Reasonable Following Its 22% Run - Simply Wall St

...

Ascendis Pharma Stock Looks Reasonable Following Its 22% Run - Simply Wall St
TipRanks 2d
Ascendis Pharma price target raised to $346 from $327 at Wedbush

Wedbush raised the firm’s price target on Ascendis Pharma (ASND) to $346 from $327 and keeps an Outperform rating on the shares. The firm says that the company’...

TipRanks 3d
Ascendis Pharma Grants 28,030 Employee Warrants

An update from Ascendis Pharma ( (ASND) ) is now available. Ascendis Pharma A/S is a pharmaceutical company focused on developing, manufacturing and selling me...

Analyst ratings

95%

of 22 ratings
Buy
95.5%
Hold
4.5%
Sell
0%

People also own

Based on the portfolios of people who own ASND. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.